Survivin Long Peptide Vaccine

Survivin long peptide vaccine · Roswell Park Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Survivin Long Peptide Vaccine, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors [Phase 1]